GOVX: GeoVax news: HIV Phase 1 vaccine major success. GeoVax updated their HIV vaccine Phase 1 work with some stunning news after the close yesterday Certainly good news for the global fight against HIV and very strong news for investors. GeoVax HIV vaccine. Phase 1 news: http://www.stockhouse.com/news/press-releases/2016/10/20/geovax-hiv-vaccine-clinical-data-presented-at-hivr4p-conference NOTE : The GOVX news likely will trigger the milestone awards that are pending. http://www.geovax.com/news-events/entry/2016/08/02/geovax-awarded-nih-contract-for-up-to-7-8-million-to-manufacture-hiv-vaccine-for-advanced-human-clinical-trials.html